How Long Has the CUHK Medical Centre Assisted Reproduction Centre Been Established? - Reproductive Centre Qualification Assessment

Opening: Direct Answer

The Assisted Reproduction Centre of the Chinese University of Hong Kong Medical Centre (CUHK Medical Centre) officially commenced services in early 2022. As of 2025, the centre has been operating for approximately 3 years. It is one of the first specialist centres established after the opening of the CUHK Medical Centre. Although the centre itself has a short history, its core team comes from the Department of Obstetrics and Gynaecology at the Chinese University of Hong Kong and the Reproductive Centre at Prince of Wales Hospital, possessing over 30 years of clinical and research experience in reproductive medicine.

Module A: Direct Answer to the Question

1. Establishment Date and Centre Background

The Chinese University of Hong Kong Medical Centre officially opened in September 2021. As a key specialist unit of the hospital, the Assisted Reproduction Centre commenced services in early 2022 after passing the review of the Hong Kong Council on Human Reproductive Technology (HFEA). The centre is located on the fourth floor of the hospital's outpatient building, featuring dedicated egg retrieval operating theatres, an embryology laboratory, and cryostorage areas.

Within the industry, the centre's establishment date places it in a newer cohort. However, the academic system it relies on—the Chinese University of Hong Kong—has been conducting research in reproductive medicine since the 1980s, including the early introduction of Intracytoplasmic Sperm Injection (ICSI) technology and the clinical application of Preimplantation Genetic Testing (PGT). Therefore, the centre's clinical technical pathway is not starting from scratch but is built upon a mature academic system.

Module C: The Doctor's Perspective

2. Reproductive Specialist's Perspective: Establishment Date is Not the Sole Evaluation Criterion

In clinical practice, patients often ask: "How long has this centre been open? Does a short history mean the technology is inferior?" From a reproductive specialist's perspective, the establishment date is indeed one reference dimension, but it is not a core evaluation indicator. More critical evaluation dimensions include the following.

• Laboratory Quality Control Level: The air quality, temperature control, incubator stability, and embryologist experience in the embryology lab directly determine embryo developmental potential. A newly built centre using the latest equipment with a robust quality control system might even have advantages in certain aspects.
• Team Clinical Experience: The core doctors' years of practice and experience in handling complex cases (e.g., advanced maternal age, poor ovarian response, recurrent implantation failure) are more important than the centre's opening date.
• Data Transparency: Whether the centre publicly discloses authentic pregnancy rates, live birth rates, multiple pregnancy rates, cycle cancellation rates, and whether the statistical methods are standardised.
• Multidisciplinary Collaboration Capability: How smoothly the reproductive centre collaborates with departments such as genetics counselling, immunology, endocrinology, and psychological support.

Therefore, for newer institutions like the CUHK Medical Centre Assisted Reproduction Centre, it is recommended that patients focus on evaluating its laboratory configuration, doctor team background, and quality control system, rather than making a judgement based solely on the number of years since establishment.

Module D: Differences Across Age Groups

3. Selection Priorities for Different Age Groups

Patient age is a core variable influencing assisted reproduction strategies. The concerns of different age groups when selecting a reproductive centre vary significantly.

Age Group	Core Concerns	Key Evaluation Points for Reproductive Centre
≤35 years	Ovarian reserve is usually good; focus on success rate and cost-effectiveness	Cycle cancellation rate, fresh cycle pregnancy rate, frozen-thawed embryo survival rate
36-40 years	Ovarian reserve begins to decline; focus on individualised protocols	Doctor's experience, diversity of ovarian stimulation protocols, laboratory blastocyst culture capability
41-44 years	Egg quantity and quality significantly decline; focus on PGT and cumulative live birth rate	Embryo culture system, PGT technology maturity, cumulative live birth rate data
≥45 years	Very low success rate with own eggs; focus on egg/embryo donation options and legal compliance	Waiting time for egg donation, embryo bank quality, relevant legal support

When selecting a reproductive centre, individuals of advanced maternal age (especially over 40) should prioritise evaluating the centre's practical experience in managing poor ovarian response, improving egg quality, and conducting embryo genetic screening, rather than just focusing on the centre's establishment date.

Module F: Differences Between Hospitals

4. Comparison of Major Assisted Reproduction Institutions in Hong Kong

Institutions providing assisted reproduction services in Hong Kong are mainly divided into two categories: public hospital reproductive centres and private clinics. A comparison from several dimensions is provided below.

Institution Type	Representative Institutions	Establishment Date	Characteristics
Public Hospital Reproductive Centre	Prince of Wales Hospital Reproductive Centre, Queen Mary Hospital Reproductive Centre	1990s-2000s	Long history, large case volume, lower fees, but longer waiting times
Private Hospital Reproductive Centre	CUHK Medical Centre Assisted Reproduction Centre, Hong Kong Sanatorium & Hospital Reproductive Centre	2010s-2022	New equipment, fast service process, high degree of personalisation, higher fees
Private Specialist Clinics	Union Hospital Reproductive Centre, Bo De Medical Services, etc.	2000s-2010s	High flexibility, some clinics run independently by senior doctors

The CUHK Medical Centre Assisted Reproduction Centre, as a reproductive centre within a private hospital, is positioned to provide efficient, high-privacy services suitable for patients who wish to shorten waiting times and seek personalised protocols. However, it is important to note that this centre currently does not participate in the public hospital referral system; all costs must be covered out-of-pocket or by private insurance.

Module G: Most Easily Overlooked Details

5. Most Easily Overlooked Details When Choosing a Reproductive Centre

Based on practitioner observations, the following details are often overlooked by patients when selecting a reproductive centre, yet they have a direct impact on treatment outcomes.

• Laboratory Air Quality and Monitoring System: Embryos are extremely sensitive to VOCs (Volatile Organic Compounds). A newly built centre using a medical-grade purification system with continuous monitoring might actually have an advantage over older laboratories. It is advisable to ask if the centre is equipped with a continuous air quality monitoring system.
• Embryologist Team Stability: The embryologist's experience directly affects fertilisation rates, embryo development rates, and cryosurvival rates. The core embryologist's years of experience and stability are more important than the centre's establishment date.
• Statistical Scope of Cycle Cancellation Rate: Some centres only report the "pregnancy rate per transfer cycle," ignoring cycles cancelled due to no eggs, no embryos, or endometrial issues. Request the centre to provide the "live birth rate per initiated cycle" (i.e., complete data from starting ovarian stimulation to live birth).
• Multiple Pregnancy Rate Control Strategy: The extent to which elective Single Embryo Transfer (eSET) is promoted is a key indicator of whether a centre prioritises patient safety. It is important to understand the centre's multiple pregnancy rate and its relationship with patient informed consent.
• Long-term Management of Frozen Embryos: This includes cryopreservation fees, storage duration, embryo ownership, and contingency plans for unexpected events. These issues are often overlooked before treatment but can lead to disputes later.

Module I: Actual Process – Key Items for Overseas IVF Preparation

6. Key Items and Time Planning for Overseas IVF Preparation

For patients planning to undergo assisted reproduction in Hong Kong or other regions, preparation involves multiple steps. The core items are outlined below according to a timeline.

(I) Items to Complete 3-6 Months in Advance

• Basic Fertility Assessment: Includes female AMH (Anti-Müllerian Hormone), FSH, LH, E2, Antral Follicle Count (AFC), and male semen analysis (including morphology and DNA fragmentation index). These indicators help assess ovarian reserve and sperm quality, forming the basis for protocol planning.
• Chromosomal Analysis and Genetic Counselling: Peripheral blood karyotyping for both partners. Those with a family history of genetic disorders should undergo genetic counselling and, if necessary, carrier screening.
• Infectious Disease Screening: Includes Hepatitis B, Hepatitis C, HIV, Syphilis, Cytomegalovirus, Rubella virus, etc. Some screening results have an expiry date (usually 6-12 months).
• Uterine Cavity Assessment: Hysteroscopy or saline infusion sonography to rule out factors affecting embryo implantation, such as endometrial polyps, adhesions, or fibroids.

(II) Items to Complete 2-3 Months in Advance

• Document Preparation: Passport validity should be more than 6 months. Apply for a medical visa for the destination if applicable. Prepare notarised and translated marriage certificates (required by some institutions). Documentation for file creation typically includes identity proof, marriage proof, medical records, and original test reports with translations.
• Medical Record Organisation: Collect all past test reports, surgical records, and treatment summaries, especially previous ovarian stimulation protocols, embryo culture records, and transfer outcomes. This information helps doctors avoid repeating ineffective protocols.
• Lifestyle Adjustments: Quit smoking and alcohol for at least 3 months. Supplement folic acid (for the female partner) and multivitamins (for both partners). Maintain a regular sleep schedule and avoid exposure to toxic or harmful environments. A BMI between 18.5 and 24 is clearly beneficial for pregnancy outcomes.

(III) Items to Complete 1 Month in Advance

• Ovarian Stimulation Protocol Discussion: Confirm the type of ovarian stimulation protocol (antagonist protocol, mild stimulation, natural cycle, etc.) with the doctor, and understand the medication regimen and schedule.
• Confirmation of Laboratory Special Requirements: If PGT (Preimplantation Genetic Testing) is required, confirm the testing scope, biopsy method, waiting time, and costs with the laboratory in advance.
• Accommodation and Travel Arrangements: Overseas IVF typically requires a stay of 14-21 days (from ovarian stimulation to egg retrieval). Arrange accommodation, transportation, and translation services (if needed) in advance.

Module Q: Frequently Asked Questions

7. Frequently Asked Questions

Question 1: Can I still undergo overseas IVF with low AMH?

Yes. Low AMH does not mean there are no eggs, but rather a lower number of eggs. The clinician will comprehensively assess based on AMH level, AFC, age, and other factors, choosing a mild stimulation protocol, natural cycle protocol, or luteal phase stimulation protocol to retrieve eggs. When AMH is below 0.5 ng/mL, the number of eggs retrieved per cycle is usually low, and multiple cycles may be needed to obtain sufficient embryos. It is advisable to discuss the expected number of eggs retrieved and cumulative pregnancy rate with the doctor in advance.

Question 2: What preparations are needed for overseas IVF at an advanced age?

For women over 40 undergoing overseas IVF, it is recommended to complete in advance: ovarian function assessment (AMH+FSH+AFC), chromosomal karyotyping, hysteroscopy, and screening for glucose metabolism and thyroid function. The male partner is also advised to complete semen analysis and chromosomal testing. The risk of miscarriage and fetal chromosomal abnormalities increases after pregnancy in older women. Consider PGT-A (Preimplantation Genetic Testing for Aneuploidy) after informed consent.

Question 3: What are the passport validity requirements for overseas IVF?

Most countries require a passport validity of more than 6 months and at least 2 blank visa pages. Some countries (e.g., Thailand, Malaysia) offer visa-on-arrival or visa-free entry for Chinese citizens, but medical purposes may require applying for a medical visa in advance. It is recommended to confirm the document requirements with the destination reproductive centre before travel and prepare notarised and translated marriage certificates.

Question 4: Do I need to prepare my body before overseas IVF?

Yes. The core goal of preparation is to improve egg and sperm quality, not to "cure" infertility. It is recommended to start at least 3 months in advance: supplement folic acid (400-800 μg/day), Coenzyme Q10 (200-600 mg/day), and Vitamin D (adjusted based on serum levels); for the male partner, supplement zinc, selenium, and L-carnitine. Also, avoid staying up late, high-temperature environments (saunas, hot springs), and reduce caffeine intake (≤200 mg/day).

Closing: Doctor's Advice